The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Open accessAbstract
We screened small molecules to identify two compounds, which we named RSL3 and RSL5, that have increased lethality in the presence of oncogenic RAS. Counter screening with biologically active compounds defined aspects of the mechanism of action for RSL3 and RSL5, such as a nonapoptotic, MEK-dependent, and iron-dependent oxidative cell death. Erastin, a previously reported compound with RAS-selective lethality, showed similar properties. RNA interference experiments targeting voltage-dependent anion channel 3 (VDAC3), a target of erastin, demonstrated that RSL5 is a scaffold that acts through VDACs to activate the observed pathway. RSL3 activated a similar death mechanism but in a VDAC-independent manner. We found that cells transformed with oncogenic RAS have increased iron content relative to their normal cell counterparts through upregulation of transferrin receptor 1 and downregulation of ferritin heavy chain 1 and ferritin light chain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Under normal circumstances, glutathione peroxidase (GPX) neutralizes lipid peroxide to lipid alcohols, but the depletion of intracellular glutathione (GSH, GPX substrate) reduces GPX functionality (Yang and Stockwell, 2008; Friedmann Angeli et al., 2014).”
From Toxic Concentrations of Glutamate Induce Ferroptosis without Affecting Mitochondrial Respiration in Rodent Brain Slice Cultures (2026) · cites this paper as Yang and Stockwell, 2008
Experimental — accuracy not yet measuredIn the citing paper
“the ferroptosis-inhibiting effect of iron depletion by either chelators [539, 543, 548] or phosphorylase kinase catalytic subunit gamma 2 (PHKG2) knockdown [566]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [543]
In the citing paper
“The mode of cell death induced by these compounds was surprisingly found to be non-apoptotic, as cells treated with erastin and RSL3 died in the absence of apoptotic hallmarks [11, 12, 13], and in cells where the core apoptosis machinery – caspases, BAX, and BAK was suppressed [14].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [12]
In the citing paper
“The first ferroptosis-inducing compounds, erastin [11] and RSL3 [12], were discovered using high-throughout screening of small molecule libraries [11, 12].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [12]
In the citing paper
“Cell death induced by RSL3 shares common features with erastin-mediated ferroptosis, such as iron, MEK, and ROS dependencies [12].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [12]
In the citing paper
“Moreover, iron chelators were identified as inhibitors of cell death induction, after RSL3 treatment, revealing the requirement of cellular iron [12].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [12]
In the citing paper
“Cells are also desensitized to ferroptosis through genetic silencing of iron uptake (TfR1), metabolism (IRP2 and ISCU) and storage (ferritin) genes [62], [66], [82], or through depletion of transferrin in the extracellular environment [83].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [66]
In the citing paper
“Cell death elicited by ferroptosis-inducing compounds (FINs) (e.g. erastin and RSL3) can also be mitigated through various iron chelators (Dfo, 2,2-bipyridile or compound 311) [62], [66], [81].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [66]
In the citing paper
“Ferroptosis, a unique cell death pathway distinct from apoptosis [62], [66], [80], is reliant on the availability of iron [62], [66], [81] liberated through ferritinophagy [63].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [66]
In the citing paper
“two structurally different inducers of ferroptosis that affect distinct pathways [66].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDiscovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C. A., Lynch, M., Lowinger, T., Dumas, J., Smith, R., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature reviews. Drug discovery · doi:10.1038/nrd2130 · Cited by 1,651
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Self-citationDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Self-citationEnhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B. L., THOMAS, G. V., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 971
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A. P., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 970
Cited by
Sorted by citations
Items 301–400 of 1,002
Ferroptosis of immune cells in the tumor microenvironment
Kim, R., Taylor, D. K., Vonderheide, R. H., & Gabrilovich, D. I. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.005 · Cited by 143
Cold stress‐induced ferroptosis involves the ASK1‐p38 pathway
Hattori, K., Ishikawa, H., Sakauchi, C., Takayanagi, S., Naguro, I., & Ichijo, H. (2017) · EMBO Reports · doi:10.15252/embr.201744228 · Cited by 134
The role of ferroptosis in lung cancer
Wu, S., Zhu, C., Tang, D., Dou, Q. P., Shen, J., & Chen, X. (2021) · Biomarker Research · doi:10.1186/s40364-021-00338-0 · Cited by 137
Decoding ferroptosis for cancer therapy
Wahida, A., & Conrad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00864-1 · Cited by 168
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 134
Moosmayer, D., Hilpmann, A., Hoffmann, J., Schnirch, L., Zimmermann, K. C., Badock, V., Furst, L., Eaton, J. K., Viswanathan, V. S., Schreiber, S. L., et al. (2021) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798320016125 · Cited by 131
David, S., Jhelum, P., Ryan, F., Jeong, S. Y., & Kroner, A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0218 · Cited by 134
Li, C., Wu, Z., Xue, H., Gao, Q., Zhang, Y., Wang, C., & Zhao, P. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13973 · Cited by 132
Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
Liu, P., Zhang, Z., Cai, Y., Li, Z., Zhou, Q., & Chen, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102201 · Cited by 137
Diacylfuroxans Are Masked Nitrile Oxides That Inhibit GPX4 Covalently
Eaton, J. K., Ruberto, R. A., Kramm, A., Viswanathan, V. S., & Schreiber, S. L. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b10769 · Cited by 131
Saponin Formosanin C-Induced Ferritinophagy and Ferroptosis in Human Hepatocellular Carcinoma Cells
Lin, P.-L., Tang, H. F., Wu, S., Shaw, N.-S., & Su, C. (2020) · Antioxidants · doi:10.3390/antiox9080682 · Cited by 129
Lipids as mediators of cancer progression and metastasis
Vogel, F. C. E., Chaves‐Filho, A. B., & Schulze, A. (2024) · Nature Cancer · doi:10.1038/s43018-023-00702-z · Cited by 141
Novel insights on targeting ferroptosis in cancer therapy
Zuo, S., Yu, J., Pan, H., & Lu, L. (2020) · Biomarker Research · doi:10.1186/s40364-020-00229-w · Cited by 128
Novel insights into ferroptosis: Implications for age-related diseases
Zhou, R., Chen, Y., Wei, X., Yu, B., Xiong, Z., Lu, C., & Hu, W. M. (2020) · Theranostics · doi:10.7150/thno.50663 · Cited by 134
Zhao, T., Yu, Z., Zhou, L., Wang, X., Hui, Y., Mao, L., Fan, X., Wang, B., Zhao, X., & Sun, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01173-4 · Cited by 128
Zhang, W., Dai, J., Hou, G., Liu, H., Zheng, S., Wang, X., Lin, Q., Zhang, Y., Lu, M., Gong, Y., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.042 · Cited by 125
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 133
Ferroptotic therapy in cancer: benefits, side effects, and risks
Diao, J., Jia, Y., Dai, E., Liu, J., Kang, R., Tang, D., Han, L., Zhong, Y., & Meng, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01999-9 · Cited by 135
Huo, H., Zhou, Z., Qin, J., Liu, W., Wang, B., & Gu, Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154605 · Cited by 125
Shi, L., Liu, Y., Li, M., & Luo, Z. Y. (2021) · FEBS Journal · doi:10.1111/febs.16034 · Cited by 127
Regulatory pathways and drugs associated with ferroptosis in tumors
Wang, D., Tang, L. M., Zhang, Y., Ge, G., Jiang, X., Mo, Y., Wu, P., Deng, X., Li, L., Zuo, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04927-1 · Cited by 131
Gao, G., Xie, Z., Li, E.-W., Yuan, Y., Fu, Y., Wang, P., Zhang, X., Qiao, Y., Xu, J., Hölscher, C., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01491-4 · Cited by 124
Cheu, J. W., Lee, D. P. H., Li, Q., Goh, C. C., Bao, M. H., Yuen, V. W., Zhang, M. S., Yang, C., Chan, C. Y., Tse, A. P., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.001 · Cited by 126
Therapeutic inhibition of ferroptosis in neurodegenerative disease
Ryan, S. K., Ugalde, C. L., Rolland, A., Skidmore, J., Devos, D., & Hammond, T. R. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.007 · Cited by 127
Shah, R., Farmer, L. A., Zilka, O., Kessel, A. T. M. V., & Pratt, D. A. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.09.007 · Cited by 127
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 119
Cheng, Y., Song, Y., Chen, H., Li, Q., Gao, Y. Z., Lu, G., & Luo, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5005136 · Cited by 124
Identifying druggable disease-modifying gene products
Dixon, S. J., & Stockwell, B. R. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.003 · Cited by 118
Self-citationLi, S., & Huang, Y. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02669-8 · Cited by 122
Yang, H., Yao, X., Liu, Y., Shen, X., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c04632 · Cited by 122
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang, S., Luo, J., Zhang, Z., Dong, D., Shen, Y., Fang, Y., Hu, L., Liu, M., Dai, C., Peng, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 117
Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
Feng, Q., Yu, X., Qiao, Y., Pan, S., Wang, R., Zheng, B., Wang, H., Ren, K., Liu, H., & Yang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858676 · Cited by 118
When ferroptosis meets pathogenic infections
Gao, J., Wang, Q., Tang, Y.-D., Zhai, J., Hu, W., & Zheng, C. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.11.006 · Cited by 118
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120
Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response
Shakya, A., McKee, N. W., Dodson, M. B., Chapman, E., & Zhang, D. D. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0005 · Cited by 120
Small-molecule allosteric inhibitors of GPX4
Liu, H., Forouhar, F., Lin, A. J., Wang, Q., Polychronidou, V., Soni, R. K., Xia, X., & Stockwell, B. R. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.11.003 · Cited by 120
Self-citationErastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
Pan, X., Lin, Z., Jiang, D., Yu, Y., Yang, D., Zhou, H., Zhan, D., Liu, S., Peng, G., Chen, Z., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9888 · Cited by 117
Yi, J., Wu, S., Tan, S., Qin, Y., Wang, X., Jiang, J., Liu, H., & Wu, B. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00768-7 · Cited by 117
The mechanisms of ferroptosis and its role in alzheimer’s disease
Ma, H., Dong, Y., Chu, Y., Guo, Y., & Li, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.965064 · Cited by 115
Yang, X., Kawasaki, N. K., Min, J., Matsui, T., & Wang, F. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.004 · Cited by 117
The Potential Role of Ferroptosis in Neonatal Brain Injury
Wu, Y., Song, J., Wang, Y., Wang, X., Culmsee, C., & Zhu, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00115 · Cited by 116
Ferroptosis: Final destination for cancer?
Zeng, Y., Liu, W., Zhuo, Q., Hu, Q., Liu, M., Sun, Q., Zhang, Z., Fan, G., Xu, W., Ji, S., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12761 · Cited by 116
Liu, Y., Zeng, L., Yang, Y., Chen, C., Wang, D. W., & Wang, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02948-2 · Cited by 117
β-Carbolines as potential anticancer agents
Aaghaz, S., Sharma, K., Jain, R., & Kamal, Ä. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113321 · Cited by 118
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117
Neuroprotective effect of deferoxamine on erastin-induced ferroptosis in primary cortical neurons
Zhang, Y., Fan, B., Pang, Y.-L., Shen, W., Wang, X., Zhao, C.-X., Li, W.-X., Liu, C., Kong, X.-H., Ning, G.-Z., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274344 · Cited by 116
Zhu, G., Murshed, A., Li, H., Ma, J., Zhen, N., Ding, M., Zhu, J., Mao, S., Tang, X., Liu, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00468-2 · Cited by 113
Global organelle profiling reveals subcellular localization and remodeling at proteome scale
Hein, M. Y., Peng, D., Todorova, V., McCarthy, F., Kim, K., Liu, C., Savy, L., Januel, C., Baltazar-Nunez, R., Sekhar, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.11.028 · Cited by 130
The Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 115
Fang, Y., Gao, S., Wang, X., Cao, Y., Lü, J., Chen, S., Lenahan, C., Zhang, J. H., Shao, A., & Zhang, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00068 · Cited by 114
The Multifaceted Regulation of Mitochondria in Ferroptosis
Wu, H., Wang, F., Ta, N., Zhang, T., & Gao, W. (2021) · Life · doi:10.3390/life11030222 · Cited by 111
Li, J., Li, M., Li, L., Ma, J., Yao, C., & Yao, S. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.003 · Cited by 111
Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy
Zhao, T., Yang, Q., Xi, Y., Xie, Z., Shen, J., Li, Z., Li, Z., & Qin, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.779585 · Cited by 111
Ferroptosis in colorectal cancer: a future target?
Yan, H. Y., Talty, R., Aladelokun, O. B., Bosenberg, M., & Johnson, C. H. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02149-6 · Cited by 115
Zheng, Y., Sun, L., Guo, J., & Ma, J. (2023) · 癌症：英文版 · doi:10.1002/cac2.12487 · Cited by 115
Sun, T., & Chi, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.05.004 · Cited by 111
Metabolic networks in ferroptosis (Review)
Hao, S., Liang, B., Huang, Q., Dong, S., Wu, Z., He, W., & Shi, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8066 · Cited by 109
Baruah, P., Moorthy, H., Ramesh, M., Padhi, D., & Govindaraju, T. (2023) · Chemical Science · doi:10.1039/d3sc02350h · Cited by 110
Maher, P. A., Currais, A. J. M., & Schubert, D. A. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.10.010 · Cited by 110
Metabolic regulation of ferroptosis in the tumor microenvironment
Mbah, N. E., & Lyssiotis, C. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101617 · Cited by 113
Ferroptosis and the tumor microenvironment
Cui, K., Wang, K., & Huang, Z. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03235-0 · Cited by 120
An overview of ferroptosis in non-alcoholic fatty liver disease
Wang, S., Liu, Z., Geng, J., Li, L., & Feng, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113374 · Cited by 107
The Mechanism of Ferroptosis and Applications in Tumor Treatment
Lin, X., Ping, J., Wen, Y., & Wu, Y. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01061 · Cited by 107
Cong, L., Dong, X., Wang, Y., Deng, Y., Li, B., & Dai, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.039 · Cited by 102
Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?
Shen, L., Lin, D., Li, X., Wu, H., Lenahan, C., Pan, Y., Xu, W., Chen, Y., Shao, A., & Zhang, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00594 · Cited by 102
Zhang, H., Zhang, E., & Hu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9111660 · Cited by 104
Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
Yang, X., & Yang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.853822 · Cited by 110
Liu, J., Huang, C., Liu, J., Meng, C., Gu, Q., Du, X., Yan, M., Yu, Y., Liu, F., & Xia, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106563 · Cited by 104
Bouchaoui, H., Mahoney‐Sanchez, L., Garçon, G., Berdeaux, O., Alleman, L., Devos, D., Duce, J. A., & Devedjian, J.-C. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.086 · Cited by 112
Van San, E., Debruyne, A. C., Veeckmans, G., Tyurina, Y. Y., Tyurin, V. A., Zheng, H., Choi, S. M., Augustyns, K., van Loo, G., Michalke, B., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01195-0 · Cited by 103
Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Zhu, S., Yu, Q., Huo, C., Li, Y., He, L., Ran, B., Chen, J., Li, Y., & Liu, W. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200121124404 · Cited by 104
Regulated Necrosis in Atherosclerosis
Puylaert, P., Zurek, M., Rayner, K. J., Meyer, G. R. Y. D., & Martinet, W. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318177 · Cited by 111
The Chemical Reactivity of Membrane Lipids
Duché, G., & Sanderson, J. M. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00608 · Cited by 111
Synthetic lethality: a framework for the development of wiser cancer therapeutics
Kaelin, W. G. (2009) · Genome Medicine · doi:10.1186/gm99 · Cited by 102
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104
Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome
Beharier, O., Kajiwara, K., & Sadovsky, Y. (2021) · Placenta · doi:10.1016/j.placenta.2021.03.007 · Cited by 106
Ferroptosis in Different Pathological Contexts Seen through the Eyes of Mitochondria
Otašević, V., Vučetić, M., Grigorov, I., Martinović, V., & Stančić, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5537330 · Cited by 104
Huang, S., Wang, Y., Xie, S., Lai, Y., Mo, C., Zeng, T., Kuang, S., Zhou, C., Zeng, Z., Chen, Y., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154117 · Cited by 102
Jin, Y., Qiu, J., Lu, X., & Li, G. (2022) · Cells · doi:10.3390/cells11244127 · Cited by 102
Grießer, M., Shah, R., Kessel, A. T. V., Zilka, O., Haidasz, E. A., & Pratt, D. A. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b00998 · Cited by 101
Targeting Lipid Peroxidation for Cancer Treatment
Clemente, S. M., Martínez-Costa, Ó. H., Monsalve, M., & Samhan-Arias, A. K. (2020) · Molecules · doi:10.3390/molecules25215144 · Cited by 100
Role of ferroptosis in neurological diseases
Yao, M.-Y., Liu, T., Zhang, L., Wang, M., Yang, Y., & Gao, J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135614 · Cited by 101
The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment
Hu, H., Chen, Y., Jing, L., Zhai, C., & Shen, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.710963 · Cited by 101
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis
Belavgeni, A., Bornstein, S. R., von Mäßenhausen, A., Tonnus, W., Stumpf, J., Meyer, C., Othmar, E., Latk, M., Kanczkowski, W., Kroiß, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912700116 · Cited by 101
Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging
Ko, M. J., Min, S., Hong, H., Yoo, W., Joo, J., Zhang, Y. S., Kang, H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.015 · Cited by 101
Kahn-Kirby, A. H., Amagata, A., Maeder, C. I., Mei, J. J., Sideris, S., Kosaka, Y., Hinman, A., Malone, S. A., Bruegger, J. J., Wang, L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214250 · Cited by 100
Targeting ferroptosis as a vulnerability in pulmonary diseases
Yang, L., Cao, L., Zhang, X., & Chu, B. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05070-7 · Cited by 101
HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
Zhang, L., Chen, F., Dong, J. P., Wang, R., Bi, G., Xu, D., Zhang, Y., Deng, Y., Lin, W., Yang, Z., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102939 · Cited by 100
Yang, K., Zeng, L., Yuan, X., Wang, S., Ge, A., Xu, H., Zeng, J., & Ge, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113611 · Cited by 98
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100
Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration
Tong, Y., Zhang, Z., & Wang, S. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.926627 · Cited by 102
Grube, J., Woitok, M. M., Mohs, A., Erschfeld, S., Lynen, C., Trautwein, C., & Otto, T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05137-5 · Cited by 93
He, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 109
Ferroptosis: Biological Rust of Lipid Membranes
Hassannia, B., Coillie, S. V., & Berghe, T. V. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8175 · Cited by 93
The Latest View on the Mechanism of Ferroptosis and Its Research Progress in Spinal Cord Injury
Chen, Y., Liu, S., Li, J., Li, Z., Quan, J., Liu, X., Tang, Y., & Liu, B. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6375938 · Cited by 100
Guo, J., Duan, L., He, X., Li, S., Wu, Y., Xiang, G., Bao, F., Yang, L., Shi, H., Gao, M., et al. (2021) · Advanced Science · doi:10.1002/advs.202004680 · Cited by 94
Ferroptosis and Autoimmune Diseases
Lai, B., Wu, C., Wu, C., Luo, S., & Lai, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916664 · Cited by 95
Kasukabe, T., Honma, Y., Okabe‐Kado, J., Higuchi, Y., Kato, N., & Kumakura, S. (2016) · Oncology Reports · doi:10.3892/or.2016.4867 · Cited by 93
Sodium iodate induces ferroptosis in human retinal pigment epithelium ARPE-19 cells
Liu, B., Wang, W., Shah, A. A., Yu, M., Liu, Y., He, L., Dang, J., Yang, L., Yan, M., Ying, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03520-2 · Cited by 94
Metadata
- Authors
- Yang, W. S., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Corresponding author
- Stockwell, Brent R.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 15
- Issue
- 3
- Pages
- 234-245
- ISSN
- 1074-5521 (ISSN-L)
- PMC
- PMC2683762
- OpenAlex
- W2114138419
- Cited by
- 1,876
- References
- 35
- Citations by year
- 2026: 138 · 2025: 231 · 2024: 319 · 2023: 312 · 2022: 271 · 2021: 202 · 2020: 135 · 2019: 66 · 2018: 58 · 2017: 38 · 2016: 35 · 2015: 19 · 2014: 11 · 2013: 7 · 2012: 10
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Chemistry & Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA097061)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- synthetic lethality, oncogenic Ras, RSL3, erastin, non-apoptotic cell death, iron-dependent cell death, oxidative cell death, VDAC3, voltage-dependent anion channel, transferrin receptor 1, ferritin, iron metabolism, small molecule screening, cancer cell death
- MeSH terms
- Drug Evaluation, Preclinical, Humans, Iron, Mutation, Neoplasms, Piperazines, Substrate Specificity, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins p21(ras), Cell Death, Apoptosis, Cell Line, Tumor, Voltage-Dependent Anion Channels, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
